Federally qualified health centers in New York received $135 million lump sum payments this week to partially offset expected 340B [...] …
Year: 2023
Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: Ensure 340B program compliance by frequently changing how you audit claims.
Audits help stakeholders confirm that
The U.S. Senate Finance Committee could mark up a pharmacy benefit manager reform bill next week with Medicaid managed care [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. House Energy & Commerce Committee plans to circulate a draft drug shortage bill in the coming weeks, committee [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal district judge in Sacramento, Calif., recently dismissed a lawsuit aimed at reversing the state’s January 2022 transfer of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B drug pricing program has evolved from a “buy low, sell low” program to help safety-net hospitals serve low-income [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health system greed has “made a mockery” of the 340B drug pricing program and leads to practices that widen health [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Medicare Part B plans to continue paying the statutory default rate—generally average sales price plus 6%—for 340B acquired drugs and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Chamber of Commerce asked a federal district court in Ohio last week to stop Medicare from implementing the [...] …